philadelphia inquirer, march 15, 2005
drug ads shifting under pressure
moved by the recall of the pain pill vioxx, one of the most heavily advertised drugs of all time, the fda has begun warning companies that it will crack down on ads that muddle drug risks. there is also talk in congress about limiting consumer ads, an industry lobbyist says. while the rules have not changed, companies may not be waiting. industry consultants say many companies are - or should be - considering a shift in ad strategy.